Kariya Pharmaceuticals is a biotechnology company developing innovative disease modifying agents to treat neurodegenerative diseases such as Parkinson’s and Alzheimer’s Disease. Kariya is supported by funding from the Novo Nordisk Foundation’s Biolnnovation Institute and Innovation Fund Denmark.
Kariya Pharmaceuticals, biotechnology company, neurodegenerative diseases, Parkinson’s, Alzheimer’s Disease, funding from the Novo Nordisk Foundation’s Biolnnovation Institute and Innovation Fund Denmark, Ian Laquian
